Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Multiple Myeloma: Elderly Patients

Multiple Myeloma: High Risk Cytogenetics

Multiple Myeloma: Renal Impairment

Lenalidomide Refractory Patients

Multiple Myeloma: Minimal Residual Disease

Multiple Myeloma: Chromosome 1q+ cytogenetic abnormalities

Gaucher disease awareness month video

What can biologic treatment do for patients with CRS with nasal polyps?

Rethink Your Nasal Polyps. Type 2 Inflammation A Nasal Polyp Mystery

Pneumology Meets Oto-Rhino-Laryngology: A Discussion of Type 2 Inflammation in Airway Diseases

Hear From An Expert On Would You Consider A Biologic For A Surgery-Naïve Patient With Crs With Nasal Polyps?

Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.